BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  KORU Medical Systems to Participate in Upcoming Investor Conferences - November 13, 2025

  November 14, 2025

   · 

  1 min read
• Press Releases

  NEUPATH HEALTH REPORTS THIRD QUARTER 2025 RESULTS

  November 14, 2025

   · 

  11 min read
• Press Releases

  AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

  November 14, 2025

   · 

  7 min read
• Press Releases

  Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results

  November 14, 2025

   · 

  8 min read
• Press Releases

  Entero’s Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

  November 14, 2025

   · 

  2 min read
• Press Releases

  Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

  November 14, 2025

   · 

  18 min read
• Press Releases

  AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

  November 14, 2025

   · 

  10 min read
• Press Releases

  Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

  November 14, 2025

   · 

  4 min read
• Press Releases

  Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented

  November 14, 2025

   · 

  6 min read
• Press Releases

  Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

  November 14, 2025

   · 

  6 min read